CoChat

Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population

Open access
Bosch, L.J.W., Melotte, V., Mongera, S., Daenen, K.L.J., Coupé, V.M.H., van Turenhout, S.T., Stoop, E.M., de Wijkerslooth, T.R., Mulder, C.J.J., Rausch, C., Kuipers, E.J., Dekker, E., Domanico, M.J., Lidgard, G.P., Berger, B.M., van Engeland, M., Carvalho, B., Meijer, G.A. · 2019 · American Journal of Gastroenterology
Cited by 98

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: We set out to evaluate the performance of a multitarget stool DNA (MT-sDNA) in an average-risk colonoscopy-controlled colorectal cancer (CRC) screening population. MT-sDNA stool test results were evaluated against fecal immunochemical test (FIT) results for the detection of different lesions, including molecularly defined high-risk adenomas and several other tumor characteristics. METHODS: Whole stool samples (n = 1,047) were prospectively collected and subjected to an MT-sDNA test, which tests for KRAS mutations, NDRG4 and BMP3 promoter methylation, and hemoglobin. Results for detecting CRC (n = 7), advanced precancerous lesions (advanced adenoma [AA] and advanced serrated polyps; n = 119), and non-AAs (n = 191) were compared with those of FIT alone (thresholds of 50, 75, and 100 hemoglobin/mL). AAs with high risk of progression were defined by the presence of specific DNA copy number events as measured by low-pass whole genome sequencing. RESULTS: The MT-sDNA test was more sensitive than FIT alone in detecting advanced precancerous lesions (46% (55/119) vs 27% (32/119), respectively, P < 0.001). Specificities among individuals with nonadvanced or negative findings (controls) were 89% (791/888) and 93% (828/888) for MT-sDNA and FIT testing, respectively. A positive MT-sDNA test was associated with multiple lesions (P = 0.005), larger lesions (P = 0.03), and lesions with tubulovillous architecture (P = 0.04). The sensitivity of the MT-sDNA test or FIT in detecting individuals with high-risk AAs (n = 19) from individuals with low-risk AAs (n = 52) was not significantly different. DISCUSSION: In an average-risk screening population, the MT-sDNA test has an increased sensitivity for detecting advanced precancerous lesions compared with FIT alone. AAs with a high risk of progression were not detected with significantly higher sensitivity by MT-sDNA or FIT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.14309/ajg.0000000000000445

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 98

Metadata

Authors
Bosch, L. J. W., Melotte, V., Mongera, S., Daenen, K. L. J., Coupé, V. M. H., van Turenhout, S. T., Stoop, E. M., de Wijkerslooth, T. R., Mulder, C. J. J., Rausch, C., Kuipers, E. J., Dekker, E., Domanico, M. J., Lidgard, G. P., Berger, B. M., van Engeland, M., Carvalho, B., & Meijer, G. A.
Venue
American Journal of Gastroenterology
Published
2019-11-25
Volume
114
Issue
12
Pages
1909-1918
ISSN
  • 0002-9270 (ISSN-L)
  • 1572-0241
OpenAlex
W2991347757
Cited by
98
References
7
FWCI
3.90
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population. https://app.cochat.ai/papers/10.14309/ajg.0000000000000445
The paper
Bosch, L. J. W., Melotte, V., Mongera, S., Daenen, K. L. J., Coupé, V. M. H., van Turenhout, S. T., Stoop, E. M., de Wijkerslooth, T. R., Mulder, C. J. J., Rausch, C., Kuipers, E. J., Dekker, E., Domanico, M. J., Lidgard, G. P., Berger, B. M., van Engeland, M., Carvalho, B., & Meijer, G. A. (2019). Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population. American Journal of Gastroenterology. https://doi.org/10.14309/ajg.0000000000000445

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.